首页> 外文期刊>Clinical & developmental immunology. >Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A
【24h】

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A

机译:MiR-362的异常表达通过Sema3a的下调促进肺癌转移

获取原文
           

摘要

miR-362 is a recently discovered member of the microRNA family, and it modulates a variety of physical activities and plays an important role in the occurrence and development of many tumors. However, the biological functions of hsa-miR-362-5p in non-small-cell lung carcinoma (NSCLC) are unknown. Transwell assay and colony formation were used to determine the migration, invasion, and proliferation of NSCLC cells in vitro . A subcutaneous tumor model in nude mice was established to detect NSCLC tumor growth in vivo . The direct binding of miR-362 to the 3′UTR of Semaphorin 3A (Sema3A) was confirmed by luciferase reporter assay. In this study, we found that the level of miR-362 was higher in NSCLC tissues than in adjacent normal tissues and that the level of miR-362 expression was also elevated in five NSCLC cell lines (A549, 95-D, H1299, H292, and H460) relative to a human normal lung epithelial cell line (BEAS2B). Furthermore, miR-362 promoted NSCLC cell invasion, migration, and colony formation in vitro and tumor formation in vivo . Next, we identified the miR-362 target gene Sema3A, which is significantly correlated with metastasis. Sema3A expression was increased in normal tissues relative to NSCLC tissues. This result is consistent with the fact that miR-362 expression is negatively correlated with Sema3A expression in clinical tissue samples and indicated that miR-362 can regulate Sema3A expression in NSCLC cells and consequently affect NSCLC invasion, migration, and colony formation. Taken together, these findings on the newly identified miR-362/Sema3A axis elucidate the molecular mechanism of NSCLC invasion and migration and could lead to a potential therapeutic target in NSCLC treatment.
机译:MiR-362是最近发现的MicroRNA系列成员,它调节了各种体育活动,并在许多肿瘤的发生和发展中起着重要作用。然而,在非小细胞肺癌(NSCLC)中HSA-MIR-362-5P的生物学功能是未知的。 Transwell测定和菌落形成用于确定体外NSCLC细胞的迁移,侵袭和增殖。建立了裸鼠的皮下肿瘤模型,以检测体内NSCLC肿瘤生长。 MiR-362至荧光素3a(Sema3a)的直接结合由荧光素酶报告结果证实。在这项研究中,我们发现,在相邻的正常组织中,miR-362的水平高于相邻的正常组织,并且MiR-362表达的水平也在五个NSClc细胞系中升高(A549,95-D,H1299,H292和H460)相对于人正常肺上皮细胞系(BEA2B)。此外,miR-362促进了体内体外和肿瘤形成的NSCLC细胞侵袭,迁移和菌落形成。接下来,我们鉴定了miR-362靶基因Sema3a,其与转移显着相关。相对于NSCLC组织的正常组织中,SEMA3A表达增加。该结果与MIR-362表达与临床组织样品中的SEMA3A表达呈负相关,并表明MIR-362可以调节NSCLC细胞中的SEMA3A表达,并因此影响NSCLC侵袭,迁移和菌落形成。结合在一起,新鉴定的miR-362 / sema3a轴上的这些发现阐明了Nsclc侵袭和迁移的分子机制,并且可能导致NSCLC治疗中的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号